September 2025 Summaries

Novartis Pharmaceuticals leveraged Dataiku's powerful platform to tackle critical business challenges in the fast-paced pharmaceutical industry, achieving significant efficiency gains and fostering a culture of innovation. By adopting Dataiku's LLM Mesh and GenAI builder capabilities, Novartis drastically reduced the time needed to develop GenAI chatbots, which enhanced their ability to conduct healthcare market research by streamlining the analysis of extensive data, such as interview transcripts. The integration of Dataiku enabled a 90% reduction in time to insights for their GenAI use case and a 600% acceleration in data ingestion time for spreadsheet tasks, transforming manual, time-consuming processes into automated, real-time analyses. This advancement not only democratized data access and improved decision-making agility but also empowered data practitioners and citizen data scientists across the organization. With automated ML model solutions, real-time data refreshes, and intuitive dashboards, Novartis improved its operational performance, reduced costs, and increased its confidence in data-driven decisions, aligning with its vision to advance in an AI- and data-driven future.

Johnson & Johnson's Vision team partnered with Dataiku to host a two-day event focused on generative AI and large language models, aiming to enhance digital skills and foster a culture of innovation. The event brought together over 650 employees from various departments, including analytics, data science, and commercial teams, who participated in a structured program featuring theoretical sessions, hands-on projects, and a hackathon. This collaboration allowed teams to develop working prototypes that could revolutionize patient care and operational efficiency, covering areas such as vision care, surgical vision, and customer insights. The success of the event highlighted the effectiveness of the Dataiku platform in enabling rapid prototyping and collaborative innovation, strengthening the ongoing partnership between J&J Vision and Dataiku, and reinforcing a unified analytics and machine learning approach across the organization.

The role of the Chief Information Officer (CIO) has evolved beyond maintaining IT systems to encompass leadership in navigating ambiguity, enabling the responsible use of generative AI (GenAI), and shaping digital ethics in real-time. In a podcast episode, Mark Booth of Perdue Farms and Mark Goldberg of the British Columbia Lottery Corporation discuss how modern CIOs must act as listeners, risk-takers, and change enablers, emphasizing the criticality of a holistic approach to AI that integrates data, business outcomes, and technology. Both CIOs illustrate the practical application of GenAI in their respective industries—agriculture and gaming—demonstrating its potential to enhance customer understanding and responsible gambling through projects rooted in data-driven insights. They stress the importance of managing the complexities of GenAI, noting that success comes from embracing uncertainty and aligning technology with strategic business goals. Ultimately, they highlight that effective GenAI leadership arises from fostering systems, strategies, and cultures that support AI's integration into decision-making processes, underscoring the role of clear vision and purpose in achieving meaningful transformation.

Dataiku has developed a Clinical Trial Intelligence Agent, a multi-agent system designed to streamline the clinical operations process by dynamically querying and synthesizing information from various sources. This system allows business users to interact with data using natural language, enabling faster and more informed decisions that can expedite the delivery of therapies to patients. The framework operates within a Dataiku visual webapp called Agent Connect, which provides a no-code environment for constructing multi-agent systems and features a conversational interface for users. Key functionalities include the ability to search and compare clinical studies, prioritize sites based on custom criteria, identify leading investigators, and generate competitiveness reports. The system's architecture involves a hierarchical structure with an orchestrator managing specialized agents and subagents, facilitating tasks such as semantic searches and API queries. Dataiku’s platform supports both no-code and code-based agents, offering a unified environment for creating and managing these systems with capabilities like instant testing, version control, and integration with external AI tools and models. This approach emphasizes efficiency, reusability, and governance, allowing users to leverage a broad AI ecosystem to enhance clinical trial intelligence.